Search Results - "Hauser, I A"

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients by Humar, A., Lebranchu, Y., Vincenti, F., Blumberg, E. A., Punch, J. D., Limaye, A. P., Abramowicz, D., Jardine, A. G., Voulgari, A. T., Ives, J., Hauser, I. A., Peeters, P.

“…Late‐onset cytomegalovirus (CMV) disease is a significant problem with a standard 3‐month prophylaxis regimen. This multicentre, double‐blind, randomized…”
Get full text

A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients by Vincenti, F., Schena, F. P., Paraskevas, S., Hauser, I. A., Walker, R. G., Grinyo, J.

“…In a randomized, open‐label, multicenter study, de novo renal transplant patients received no steroids (n = 112), steroids to day 7 (n = 115), or standard…”
Get full text

A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection by Pliquett, R. U., Asbe-Vollkopf, A., Hauser, P. M., Presti, L. L., Hunfeld, K. P., Berger, A., Scheuermann, E. H., Jung, O., Geiger, H., Hauser, I. A.

“…Pneumocystis jirovecii pneumonia (PCP) and cytomegalovirus (CMV) infection represent possible complications of medical immunosuppression. Between 2005 and…”
Get full text

IL-18 is expressed in the intercalated cell of human kidney by Gauer, S., Sichler, O., Obermüller, N., Holzmann, Y., Kiss, E., Sobkowiak, E., Pfeilschifter, J., Geiger, H., Mühl, H., Hauser, I.A.

“…We determined the cellular location of interleukin-18 (IL-18) and caspase-1 and the purinergic receptor P2X7, two proteins necessary for its activation and…”
Get full text

Human Pregnane X Receptor Genotype of the Donor but Not of the Recipient Is a Risk Factor for Delayed Graft Function After Renal Transplantation by Hauser, I A, Kruck, S, Gauer, S, Nies, A T, Winter, S, Bedke, J, Geiger, H, Hoefeld, H, Kleemann, J, Asbe-Vollkopf, A, Engel, J, Burk, O, Schwab, M, Schaeffeler, E

“…Delayed graft function (DGF) is an important complication in renal transplantation, contributing significantly to decrease in long‐term allograft survival. In…”
Get full text

Mechanisms of Everolimus‐Induced Glomerulosclerosis After Glomerular Injury in the Rat by Daniel, C., Renders, L., Amann, K., Schulze‐Lohoff, E., Hauser, I.A., Hugo, C.

“…Despite the lack of nephrotoxicity, adverse effects of the new antiproliferative immunosuppressant everolimus have been reported. By varying time point and…”
Get full text

Can the Preprocurement Pancreas Suitability Score Predict Ischemia-Reperfusion Injury and Graft Survival After Pancreas Transplantation? by Woeste, G, Moench, C, Hauser, I.A, Geiger, H, Scheuermann, E, Bechstein, W.O

“…Abstract Background Ischemia-reperfusion injury (IRI) is common after pancreas transplantation, leading to pancreatitis or thrombosis with the need for…”
Get full text

Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression by Trappe, R., Hinrichs, C., Appel, U., Babel, N., Reinke, P., Neumayer, H.‐H., Budde, K., Dreyling, M., Dührsen, U., Kliem, V., Schüttrumpf, S., Hauser, I. A., Mergenthaler, H.‐G., Schlattmann, P., Anagnostopoulos, I., Doerken, B., Riess, H.

“…We addressed the effect of post‐transplant lymphoproliferative disorder (PTLD) treatment with rituximab monotherapy or CHOP‐based chemotherapy (± rituximab)…”
Get full text

Incidence and Treatment of Pancreatic Fistula after Simultaneous Pancreas Kidney Transplantation by Woeste, G, Moench, C, Hauser, I.A, Geiger, H, Scheuermann, E, Bechstein, W.O

“…Abstract Background Simultaneous pancreas and kidney transplantation (SPK) is associated with great postoperative morbidity, including the need for…”
Get full text

Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine by Bartel, C, Obermüller, N, Rummel, M J, Geiger, H, Hauser, I A

“…In a 56-year-old white male patient, a membranoproliferative glomerulonephritis Type I was diagnosed after a 12-month history of low grade B cell lymphoma…”
Get more information

Entry‐into‐human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients by NEUMAYER, H.-H, PARADIS, K, BURKHARDT, K, LISON, A.-E, BARNDT, I, APPEL-DINGEMANSE, S, KORN, A, JEAN, C, FRITSCHE, L, BUDDE, K, WINKLER, M, KLIEM, V, PICHLMAYR, R, HAUSER, I. A

“…Aims To evaluate the tolerability of single oral SDZ RAD doses in stable renal transplant recipients and the pharmacokinetics of ascending SDZ RAD doses when…”
Get full text

Epstein‐Barr Virus‐Associated Posttransplant Lymphoproliferative Disorder of Donor Origin after Simultaneous Pancreas–Kidney Transplantation Limited to Pancreas Allograft: A Case Report by Rehbinder, B., Wullstein, Ch, Bechstein, W. O., Probst, M., Engels, K., Kriener, S., Döbert, N., Schwarz, W., Brixner, V., Steffan, D., Gauer, S., Geiger, H., Hauser, I. A.

“…A 45‐year‐old man was admitted with fever and elevated pancreas enzymes 6 months after simultaneous pancreas–kidney transplantation (SPKT). Function of the…”
Get full text

Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion by HAUSER, I. A, RENDERS, L, RADEKE, H.-H, STERZE, R. B, GOPPELT-STRUEBE, M

“…Mycophenolate mofetil (MMF) is used for immunosuppression after renal transplantation because it reduces lymphocyte proliferation by inhibiting inosine…”
Get full text

Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells by Hauser, Ingeborg A., Koziolek, Michael, Hopfer, Ulrich, Thévenod, Frank

“…Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells. The immunosuppressive…”
Get full text

Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients by EITNER, Frank, HAUSER, IngeborgA, FISCHEREDER, Michael, RETTKOWSKI, Olaf, RATH, Thomas, LOPAU, Kai, PLIQUETT, Rainer U, FIEDLER, Roman, GUBA, Markus, HILGERS, Ralf-Dieter, FLOEGE, Jürgen

“…Pneumocystis jiroveci pneumonia (PcP) is a potentially life-threatening complication in renal transplant recipients with increased reports during the past few…”
Get full text

Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients by Budde, Klemens, Neumayer, Hans-Hellmut, Lehne, Gustav, Winkler, Michael, Hauser, Ingeborg Anni, Lison, Arno, Fritsche, Lutz, Soulillou, Jean-Paul, Fauchald, Per, Dantal, Jaques

“…Background. Current immunosuppressant regimens need to be improved to prevent acute and chronic graft rejection. The novel macrocyclic immunosuppressant…”
Get full text

Evaluation of Type 1 Diabetics for Simultaneous Pancreas-Kidney Transplantation With Regard to Cardiovascular Risk by Woeste, G., Wullstein, C., Zapletal, C., Hauser, I.A., Gossmann, J., Geiger, H., Bechstein, W.O.

“…The main cause of death for diabetic patients and patients on dialysis is coronary artery disease (CAD). The most common cause of graft loss following…”
Get full text

Clinical aspects of renal transplantation in polycystic kidney disease by Stiasny, B, Ziebell, D, Graf, S, Hauser, I A, Schulze, B D

“…Autosomal dominant polycystic kidney disease (ADPKD) as a systemic disorder represents a special subgroup among patients with end-stage renal disease (ESRD)…”
Get more information

Treatment of hirudin overdosage in a patient with chronic renal failure by Bauersachs, R M, Lindhoff-Last, E, Ehrly, A M, Betz, C, Geiger, H, Hauser, I A

Get more information

Gender dependent rate of metabolism of the opioid receptor-PET ligand [18F]fluoroethyldiprenorphine by Henriksen, G, Spilker, M E, Sprenger, T, Hauser, A I, Platzer, S, Boecker, H, Toelle, T R, Schwaiger, M, Wester, H-J

“…The morphinane-derivate 6-O-(2-[(18)F]fluoroethyl)-6-O-desmethyldiprenorphine ([(18)F]FDPN) is a nonselective opioid receptor ligand currently used in positron…”
Get more information